Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients
Frederick K. Ho, Kenneth K. C. Man, Mark Toshner, et al.
Mayo Clinic Proceedings (2021) Vol. 96, Iss. 10, pp. 2587-2597
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Betty Raman, David A. Bluemke, Thomas F. Lüscher, et al.
European Heart Journal (2022) Vol. 43, Iss. 11, pp. 1157-1172
Open Access | Times Cited: 535
Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study
Ioannis Katsoularis, Osvaldo Fonseca‐Rodríguez, Paddy Farrington, et al.
BMJ (2022), pp. e069590-e069590
Open Access | Times Cited: 310
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank
Zahra Raisi‐Estabragh, Jackie A. Cooper, Ahmed Salih, et al.
Heart (2022) Vol. 109, Iss. 2, pp. 119-126
Open Access | Times Cited: 115
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
Sally Singh, Molly M Baldwin, Enya Daynes, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 709-725
Open Access | Times Cited: 93
Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19
Junqing Xie, Albert Prats‐Uribe, Qi Feng, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 10, pp. 1063-1063
Open Access | Times Cited: 73
Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study
Celine Sze Ling Chui, Min Fan, Eric Yuk Fai Wan, et al.
EClinicalMedicine (2022) Vol. 50, pp. 101504-101504
Open Access | Times Cited: 41
Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study
Charlotte Warren‐Gash, Jennifer Davidson, Helen Strongman, et al.
The Lancet Regional Health - Europe (2023) Vol. 27, pp. 100604-100604
Open Access | Times Cited: 22
Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review
Marianne Riou, F Coste, Alain Meyer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4941-4941
Open Access | Times Cited: 8
Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
Rui‐Sheng Wang, Joseph Loscalzo
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1374-1386
Open Access | Times Cited: 16
Myocardial Infarction During the COVID-19 Pandemic
Alexander C. Fanaroff, Santiago García, Jay Giri
JAMA (2021) Vol. 326, Iss. 19, pp. 1916-1916
Open Access | Times Cited: 35
Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis
Xiaoming Wu, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 27
Acute Arterial Ischemic Stroke Following COVID-19 Vaccination
Maria‐Ioanna Stefanou, Lina Palaiodimou, Diana Aguiar de Sousa, et al.
Neurology (2022) Vol. 99, Iss. 14
Closed Access | Times Cited: 26
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
Jack Gisby, Norzawani B Buang, Artemis Papadaki, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19
Santiago García, Payam Dehghani, Larissa Stanberry, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 22, pp. 2236-2244
Open Access | Times Cited: 22
Can adverse cardiac events of the COVID-19 vaccine exacerbate preexisting diseases?
Mohammed S. Razzaque
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 4, pp. 131-137
Closed Access | Times Cited: 5
Cardiovascular disease risk after a SARS-CoV-2 infection: A systematic review and meta-analysis
Karla Romero Starke, Pauline Kaboth, Natalie Rath, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106215-106215
Open Access | Times Cited: 5
Impact of the Coronavirus Disease 2019 Pandemic on the Management and Outcomes of ST-Segment Elevation Myocardial Infarction Patients: A Retrospective Cohort Study
Cheng‐Han Yang, Yu‐Jen Lin, Shi-Ying Gao, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 422-422
Open Access
Demographic and regional trends of acute myocardial infarction-related mortality among young adults in the US, 1999–2020
Haibin Li, Jin Zheng, Frank Qian, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
The Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity
Nagihan Durmuş Koçak, Nuri Tutar, Gizem Çil, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1909-1909
Open Access
Respiratory Complications after COVID-19
Issa Al-Jahdhami, Adhra Al‐Mawali, Sami M Bennji
Oman Medical Journal (2021) Vol. 37, Iss. 1, pp. e343-e343
Open Access | Times Cited: 30
Short-term effects of PM1, PM2.5, and PM2.5 constituents on myocardial infarction mortality in qingdao, China: A time-stratified case-crossover analysis
Xiaoyun Ma, Haiping Duan, Hua Zhang, et al.
Atmospheric Environment (2022) Vol. 294, pp. 119478-119478
Closed Access | Times Cited: 16
The potential role of ferroptosis in COVID-19-related cardiovascular injury
Lei Yang, Yunyi Wu, Weidong Jin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115637-115637
Open Access | Times Cited: 10
Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review
Gaelle Massoud, Dana Hazimeh, Ghadir Amin, et al.
European Journal of Pharmacology (2023) Vol. 941, pp. 175501-175501
Open Access | Times Cited: 9
Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
Azadeh Shoaibi, Patricia C. Lloyd, Hui‐Lee Wong, et al.
Vaccine (2023) Vol. 41, Iss. 32, pp. 4666-4678
Open Access | Times Cited: 9
What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19
Giuseppe Lippi, Emmanuel J. Favaloro
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 01, pp. 027-033
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top